Comparing impact of treatment before or after surgery in patients with stage II-IIIb resectable non-small cell lung cancer (NSCLC; Alliance A082304-SWOG S2402).
      Google Scholar   
Citation:
JCO vol 43 (16_suppl) TPS8113
Meeting Instance:
ASCO 2025
Year:
2025
Type:
Abstract
Sub type:
Poster General
Funding:
NCTN
Endpoint:
No-Endpoint
Analysis:
Trial-Description-Only
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
epreprint
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Respiratory
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882; U10CA180888 (SWOG);  
Corr. Author:
 
Authors:
                       
Networks:
FL065, LAPS-CT018, LAPS-MA036, LAPS-MN026, LAPS-MO011, LAPS-NC010, LAPS-OK003, VA009   
Study
CTIU2317-A082305-S2402
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords: